Primary prevention of Type 2 (non-insulin-dependent) diabetes mellitus H. KingJ. E. Dowd Review Pages: 3 - 8
B cell-adherent splenocytes precede the onset of diabetes in low-dose streptozotocin-treated mice B. FeveJ. P. SegainP. Sai Originals Pages: 9 - 14
Functional and morphological effects of interleukin-1β on the perfused rat pancreas L. D. WogensenV. Kolb-BachofenJ. Nerup Originals Pages: 15 - 23
Effect of an α-glycosidase inhibitor on experimentally-induced obesity in mice Y. Le Marchand-BrustelN. RochetE. Van Obberghen Originals Pages: 24 - 30
Type 1 (insulin-dependent) diabetes mellitus diagnosed during pregnancy: a clinical and prognostic study K. BuschardP. HougaardC. Kühl Originals Pages: 31 - 35
Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of Type 1 (insulin-dependent) diabetes mellitus O. SnorgaardS. G. HartlingC. Binder Originals Pages: 36 - 42
Inability to stimulate skeletal muscle or whole body protein synthesis in Type 1 (insulin-dependent) diabetic patients by insulin-plus-glucose during amino acid infusion: studies of incorporation and turnover of tracer L-[1-13C]leucine W. M. BennetA. A. ConnacherM. J. Rennie Originals Pages: 43 - 51
Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning G. PerrielloP. De FeoG. B. Bolli Originals Pages: 52 - 59
The third international workshop on the standardisation of insulin autoantibody measurement J. P. PalmerT. J. WilkinR. Zanchetta Workshop Report Pages: 60 - 61
Toxic effects of vanadium in streptozotocin-treated rats after administration of vanadate to normalize blood glucose levels J. L. DomingoB. Portha Letters to the Editor Pages: 62 - 63